| abstract |
The invention relates to quinoline/quinoxaline compounds which inhibit patelet-derived growth factor and/or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds,and to their use for producing preparations for the treatment of patients suffering from or subject to cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T-cell activation and proliferation. |